Current management in polycythemia vera

[1] BERK PD, 1986, SEMIN HEMATOL, V23, P132

[2] BERK PD, 1995, POLYCYTHEMIA VERA MY, P102

[3] Interferon-α therapy in polycythemia vera and essential thrombocythemia [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (05) : 463 - 472

[4] Fruchtman SM, 1997, SEMIN HEMATOL, V34, P17

[5] GIBLERT HS, 1999, INT SOC HEM ED PROGR, P141

[6] Gilbert HS, 1998, CANCER-AM CANCER SOC, V83, P1205, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1205::AID-CNCR21>3.0.CO

[7] 2-8

[8] GILBERT HS, 1991, NEOPLASTIC DIS BLOOD, P123

[9] GILBERT HS, 2000, CONNS CURRENT THERAP, P445

[10] ANAGRELIDE - A POTENT AND SELECTIVE INHIBITOR OF PLATELET CYCLIC-AMP PHOSPHODIESTERASE ENZYME-ACTIVITY [J]. BIOCHEMICAL PHARMACOLOGY, 1988, 37 (14) : 2866 - 2868

[1] BERK PD, 1986, SEMIN HEMATOL, V23, P132

[2] BERK PD, 1995, POLYCYTHEMIA VERA MY, P102

[3] Interferon-α therapy in polycythemia vera and essential thrombocythemia [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (05) : 463 - 472

[4] Fruchtman SM, 1997, SEMIN HEMATOL, V34, P17

[5] GIBLERT HS, 1999, INT SOC HEM ED PROGR, P141

[6] Gilbert HS, 1998, CANCER-AM CANCER SOC, V83, P1205, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1205::AID-CNCR21>3.0.CO

[7] 2-8

[8] GILBERT HS, 1991, NEOPLASTIC DIS BLOOD, P123

[9] GILBERT HS, 2000, CONNS CURRENT THERAP, P445

[10] ANAGRELIDE - A POTENT AND SELECTIVE INHIBITOR OF PLATELET CYCLIC-AMP PHOSPHODIESTERASE ENZYME-ACTIVITY [J]. BIOCHEMICAL PHARMACOLOGY, 1988, 37 (14) : 2866 - 2868